+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1vkx | ||||||
---|---|---|---|---|---|---|---|
タイトル | CRYSTAL STRUCTURE OF THE NFKB P50/P65 HETERODIMER COMPLEXED TO THE IMMUNOGLOBULIN KB DNA | ||||||
![]() |
| ||||||
![]() | TRANSCRIPTION/DNA / TRANSCRIPTION FACTOR / NF-KB / HETERODIMER / DNA-BINDING / TRANSCRIPTION-DNA COMPLEX | ||||||
機能・相同性 | ![]() SUMOylation of immune response proteins / Regulated proteolysis of p75NTR / I-kappaB/NF-kappaB complex / Interleukin-1 processing / DEx/H-box helicases activate type I IFN and inflammatory cytokines production / RIP-mediated NFkB activation via ZBP1 / MAP3K8 (TPL2)-dependent MAPK1/3 activation / TRAF6 mediated NF-kB activation / positive regulation of hyaluronan biosynthetic process / NF-kB is activated and signals survival ...SUMOylation of immune response proteins / Regulated proteolysis of p75NTR / I-kappaB/NF-kappaB complex / Interleukin-1 processing / DEx/H-box helicases activate type I IFN and inflammatory cytokines production / RIP-mediated NFkB activation via ZBP1 / MAP3K8 (TPL2)-dependent MAPK1/3 activation / TRAF6 mediated NF-kB activation / positive regulation of hyaluronan biosynthetic process / NF-kB is activated and signals survival / PKMTs methylate histone lysines / Activation of NF-kappaB in B cells / TAK1-dependent IKK and NF-kappa-B activation / Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells / mammary gland involution / FCERI mediated NF-kB activation / CLEC7A (Dectin-1) signaling / Interleukin-1 signaling / antibacterial innate immune response / Downstream TCR signaling / prolactin signaling pathway / cellular response to interleukin-17 / NF-kappaB p50/p65 complex / toll-like receptor TLR6:TLR2 signaling pathway / positive regulation of Schwann cell differentiation / CD209 (DC-SIGN) signaling / positive regulation of lipid storage / cellular response to peptidoglycan / negative regulation of interleukin-12 production / ankyrin repeat binding / postsynapse to nucleus signaling pathway / negative regulation of protein sumoylation / defense response to tumor cell / cellular response to interleukin-6 / nucleotide-binding oligomerization domain containing 2 signaling pathway / cellular response to dsRNA / actinin binding / positive regulation of macrophage derived foam cell differentiation / response to UV-B / negative regulation of non-canonical NF-kappaB signal transduction / non-canonical NF-kappaB signal transduction / positive regulation of miRNA metabolic process / positive regulation of leukocyte adhesion to vascular endothelial cell / interleukin-1-mediated signaling pathway / NF-kappaB complex / vascular endothelial growth factor signaling pathway / negative regulation of cytokine production / toll-like receptor 4 signaling pathway / positive regulation of amyloid-beta formation / cellular response to hepatocyte growth factor stimulus / response to cobalamin / phosphate ion binding / cellular response to cytokine stimulus / positive regulation of T cell receptor signaling pathway / cellular response to lipoteichoic acid / : / response to muramyl dipeptide / cellular response to interleukin-1 / general transcription initiation factor binding / cellular response to angiotensin / positive regulation of vascular endothelial growth factor production / positive regulation of cholesterol efflux / canonical NF-kappaB signal transduction / hair follicle development / response to amino acid / positive regulation of transcription initiation by RNA polymerase II / neuropeptide signaling pathway / lymph node development / NF-kappaB binding / RNA polymerase II core promoter sequence-specific DNA binding / response to cAMP / tumor necrosis factor-mediated signaling pathway / JNK cascade / response to muscle stretch / antiviral innate immune response / positive regulation of interleukin-12 production / Neutrophil degranulation / negative regulation of insulin receptor signaling pathway / negative regulation of miRNA transcription / peptide binding / negative regulation of angiogenesis / liver development / response to progesterone / positive regulation of interleukin-1 beta production / response to ischemia / animal organ morphogenesis / positive regulation of interleukin-8 production / RNA polymerase II transcription regulatory region sequence-specific DNA binding / negative regulation of extrinsic apoptotic signaling pathway / B cell receptor signaling pathway / transcription coregulator activity / response to insulin / response to bacterium / protein catabolic process / defense response / positive regulation of non-canonical NF-kappaB signal transduction / negative regulation of protein catabolic process / cellular response to virus / chromatin DNA binding / positive regulation of miRNA transcription 類似検索 - 分子機能 | ||||||
生物種 | ![]() ![]() | ||||||
手法 | ![]() | ||||||
![]() | Chen, F. / Huang, D.B. / Ghosh, G. | ||||||
![]() | ![]() タイトル: Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA. 著者: Chen, F.E. / Huang, D.B. / Chen, Y.Q. / Ghosh, G. #1: ![]() タイトル: Structure of NF-Kb p50 Homodimer Bound to a Kb Site 著者: Ghosh, G. / Duyne, G.V. / Ghosh, S. / Sigler, P.B. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 141.8 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 107 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
---|
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||||
単位格子 |
|
-
要素
#1: DNA鎖 | 分子量: 3669.389 Da / 分子数: 1 / 由来タイプ: 合成 詳細: ACTIVE NF-KAPPA-B IS A HETERODIMER OF AN ABOUT 50 KD DNA-BINDING SUBUNIT AND THE WEAK DNA-BINDING SUBUNIT P65 |
---|---|
#2: DNA鎖 | 分子量: 3656.407 Da / 分子数: 1 / 由来タイプ: 合成 詳細: ACTIVE NF-KAPPA-B IS A HETERODIMER OF AN ABOUT 50 KD DNA-BINDING SUBUNIT AND THE WEAK DNA-BINDING SUBUNIT P65 |
#3: タンパク質 | 分子量: 30984.045 Da / 分子数: 1 / 由来タイプ: 天然 / 由来: (天然) ![]() ![]() |
#4: タンパク質 | 分子量: 34924.871 Da / 分子数: 1 / 由来タイプ: 天然 / 由来: (天然) ![]() ![]() |
Has protein modification | Y |
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 3.99 Å3/Da / 溶媒含有率: 59 % | ||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶化 | 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 5.5 / 詳細: pH 5.50, VAPOR DIFFUSION, HANGING DROP | ||||||||||||||||||||||||||||||||||||||||||||||||
溶液の組成 |
| ||||||||||||||||||||||||||||||||||||||||||||||||
結晶化 | *PLUS 温度: 18 ℃ | ||||||||||||||||||||||||||||||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
回折 | 平均測定温度: 105 K |
---|---|
放射光源 | 由来: ![]() |
検出器 | タイプ: MARRESEARCH / 検出器: IMAGE PLATE / 日付: 1997年4月1日 |
放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1.5418 Å / 相対比: 1 |
反射 | 解像度: 2.9→30 Å / Num. obs: 26430 / % possible obs: 97 % / Observed criterion σ(I): 1 / Rmerge(I) obs: 0.082 / Net I/σ(I): 15.8 |
反射 シェル | 解像度: 2.9→3 Å / Rmerge(I) obs: 0.45 / % possible all: 88 |
反射 | *PLUS Num. measured all: 88449 |
反射 シェル | *PLUS % possible obs: 88 % |
-
解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: MOLECULAR REPLACEMEN 開始モデル: ONE MONOMER OF P50/DNA COMPLEX AND ONE MONO OF P65/DNA COMPLEX 解像度: 2.9→8 Å / σ(F): 2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2.9→8 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ソフトウェア | *PLUS 名称: ![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 | *PLUS
|